| P50 | author | Ruud Veldhuizen | Q60730440 |
| P2093 | author name string | Valeria Puntorieri | |
| | James F Lewis | |
| | Li-Juan Yao | |
| | Lynda A McCaig | |
| | Josh Qua Hiansen | |
| P2860 | cites work | A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 |
| | Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network | Q27861021 |
| | Incidence and outcomes of acute lung injury | Q29615139 |
| | The acute respiratory distress syndrome | Q29615140 |
| | Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation | Q30442280 |
| | Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis | Q34999391 |
| | The role of exogenous surfactant in the treatment of acute lung injury | Q35041169 |
| | Mechanical ventilation interacts with endotoxemia to induce extrapulmonary organ dysfunction | Q35544743 |
| | Circulating leukotriene B4 identifies respiratory complications after trauma. | Q35864235 |
| | Causes of mortality in patients with the adult respiratory distress syndrome | Q39860867 |
| | Causes and timing of death in patients with ARDS. | Q40397144 |
| | Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial | Q40805989 |
| | Surfactant and the adult respiratory distress syndrome | Q40869111 |
| | Immunomodulatory functions of surfactant | Q40878977 |
| | Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS. | Q41337631 |
| | Leukotriene b4 and its metabolites prime the neutrophil oxidase and induce proinflammatory activation of human pulmonary microvascular endothelial cells. | Q41879867 |
| | The effect of tidal volume on systemic inflammation in Acid-induced lung injury | Q42751385 |
| | Role of cholesterol in the biophysical dysfunction of surfactant in ventilator-induced lung injury. | Q43246210 |
| | Elevated endogenous surfactant reduces inflammation in an acute lung injury model | Q43258290 |
| | Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome | Q44989188 |
| | Pulmonary surfactant: functions and molecular composition. | Q46027561 |
| | Protective effects of elevated endogenous surfactant pools to injurious mechanical ventilation. | Q46788993 |
| | A comparative study of mechanisms of surfactant inhibition | Q46883791 |
| | Differential effects of mechanical ventilatory strategy on lung injury and systemic organ inflammation in mice | Q47903838 |
| | Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury | Q48948621 |
| | Treatment of ventilation-induced lung injury with exogenous surfactant. | Q51357686 |
| | Early surfactant administration protects against lung dysfunction in a mouse model of ARDS. | Q51690181 |
| | Effect of surfactant on ventilation-induced mediator release in isolated perfused mouse lungs. | Q51699199 |
| | Early growth response-1 worsens ventilator-induced lung injury by up-regulating prostanoid synthesis. | Q54444298 |
| | Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome | Q70785180 |
| | Bovine pulmonary surfactant: chemical composition and physical properties | Q71246521 |
| | Evaluation of exogenous surfactant treatment strategies in an adult model of acute lung injury | Q71794117 |
| | Evaluation of exogenous surfactant in HCL-induced lung injury | Q73793823 |
| | Effects of ventilation strategies on the efficacy of exogenous surfactant therapy in a rabbit model of acute lung injury | Q74100412 |
| | Hyperventilation induces release of cytokines from perfused mouse lung | Q74100485 |
| | Surfactant treatment for ventilation-induced lung injury in rats: effects on lung compliance and cytokines | Q74518452 |
| | Mechanical ventilation induces inflammation, lung injury, and extra-pulmonary organ dysfunction in experimental pneumonia | Q79950079 |
| | High-frequency oscillation and surfactant treatment in an acid aspiration model | Q82775558 |
| | Lung-derived soluble mediators are pathogenic in ventilator-induced lung injury | Q83216627 |
| | Surfactant protein-A reduces translocation of mediators from the lung into the circulation | Q84751973 |
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 67 | |
| P577 | publication date | 2013-11-20 | |
| P1433 | published in | BMC Pulmonary Medicine | Q15755469 |
| P1476 | title | The effects of exogenous surfactant administration on ventilation-induced inflammation in mouse models of lung injury | |
| P478 | volume | 13 | |